{"news_desk": "Business", "print_page": null, "subsection_name": "DealBook", "section_name": "Business Day", "byline": {"original": "By AMIE TSANG", "person": [{"firstname": "Amie", "rank": 1, "lastname": "TSANG", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "541", "keywords": [{"rank": "1", "value": "Private Equity", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Ethics and Official Misconduct", "is_major": "N", "name": "subject"}, {"rank": "5", "value": "Shkreli, Martin (1983- )", "is_major": "N", "name": "persons"}, {"rank": "6", "value": "Apollo Global Management", "is_major": "N", "name": "organizations"}, {"rank": "7", "value": "LyondellBasell", "is_major": "N", "name": "organizations"}, {"rank": "8", "value": "Securities and Exchange Commission", "is_major": "N", "name": "organizations"}, {"rank": "9", "value": "Turing Pharmaceuticals AG", "is_major": "N", "name": "organizations"}], "lead_paragraph": "A private equity firm is fined for misleading investors, a once-promising relationship goes sour, and a controversial pharmaceuticals company is back in the headlines.", "pub_date": "2016-08-24T04:00:00+0000", "document_type": "article", "source": "The New York Times", "snippet": "A private equity firm is fined for misleading investors, a once-promising relationship goes sour, and a controversial pharmaceuticals company is back in the headlines....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/08/24/business/24db-newsletter/24db-newsletter-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/08/24/business/24db-newsletter/24db-newsletter-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/08/24/business/24db-newsletter/24db-newsletter-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/08/24/business/dealbook/apollo-sec-turing-lawsuit-shkreli.html", "slideshow_credits": null, "blog": [], "_id": "57bd70d595d0e021d79824af", "headline": {"main": "Morning Agenda: Fining Apollo, When Deals Go Sour, and Controversy at Turing"}}